Dr. Ann Arvin is the Lucile Salter Packard Professor of pediatrics and professor of microbiology & immunology emeritus at Stanford University, and the senior vice president at Vir Biotechnology. Her research interests include the molecular virology and pathogenesis of herpesviruses, with a focus on varicella zoster virus, immune responses of children to viral infections and vaccines and development of viral vaccines. She earned her A.B. in philosphy from Brown University, a M.A. in philosophy from Brandeis University and a M.D. from the University of Pennsylvania. She completed her clinical training in pediatrics at the University of California, San Francisco and her postdoctoral fellowship at UCSF and Stanford University.

Arvin was chief of Pediatric Infectious Diseases Division, Stanford Children’s Hospital, from 1984 to 2006. She served as the vice provost and dean of research, Stanford University from 2006 to 2018. She is a member of the American Academy of Arts & Sciences, the National Academy of Medicine, the American Association for the Advancement of Science, the Association of American Physicians and the American Pediatric Society. Her service related to infectious diseases, vaccines and policy includes the NIAID Director’s Advisory Council; the National Vaccine Advisory Committee, DHHS; the NAS/NRC Committees on Policy and Global Affairs, Science, Technology and Law, Federal Research Regulations, Responsible Science and the Board on Life Sciences; the NAM Committee on the Scientific Uses of Variola Virus; the WHO Steering Committee on Research Related to Measles Vaccines; the NIAID Blue Ribbon Panel on Influenza; the President’s Council on Science and Technology H1N1 and Influenza Working Groups and the NIH ACTIV Vaccines Working Group for COVID-19.